Pig Interferon Beta (IFNB1) Protein

Este producto es parte de IFNB1 - interferon beta 1
Product Graph
806€ (50 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Pig Interferon Beta (IFNB1) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx655692
tested applications
WB, SDS-PAGE

Description

Pig Interferon Beta (IFNB1) Protein (Active) is an Active recombinant Pig protein.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Interferon Beta (IFNB1)
Host
E. coli
Assay Type
Activity: Active
Biological Activity: Interferon Beta (IFNb) is a member of type I interferons (IFNs) family which is a large subgroup of interferon proteins that help regulate the activity of the immune system. The IFNb proteins are produced in large quantities by fibroblasts. They have antiviral activity that is involved mainly in innate immune response. Two types of IFNb have been described, IFNb1 (IFNB1) and IFNb3 (IFNB3). IFNb1 is used as a treatment for multiple sclerosis as it reduces the relapse rate. Besides, Interferon Alpha/Beta Receptor 1 (IFNa/bR1) has been identified as an interactor of IFNb, thus a binding ELISA assay was conducted to detect the interaction of recombinant Pig IFNb and recombinant Pig IFNa/bR1. Briefly, IFNb were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100ul were then transferred to IFNa/bR1-coated microtiter wells and incubated for 2 h at 37 °C .Wells were washed with PBST and incubated for 1 h with anti-IFNb polyclonal antibody, then aspirated and washed 3 times. After incubation with HRP-conjugated secondary antibody, wells were aspirated and washed 3 times. TMB substrate solution was added and wells were incubated for 15-25 min at 37 °C. Finally, 50 μl stop solution was added to the wells and the absorbance was read at 450 nm immediately. 
Sequence Fragment: Met22-Asn186
Tag: N-terminal His tag and GST tag
Origin
Pig
Conjugation
Unconjugated
Observed MW
Calculated MW: 49.62 kDa  Observed MW (SDS-PAGE): 50 kDa
Expression
Recombinant
Purity
> 98%
Size 1
50 µg
Size 2
100 µg
Size 3
200 µg
Size 4
500 µg
Size 5
1 mg
Form
Lyophilized
Tested Applications
WB, SDS-PAGE
Buffer
Prior to lyophilization: 20 mM Tris, 150 mM NaCl, pH 8.0, containing 0.01% Sarcosyl and 5% Trehalose.
Availability
Shipped within 5-7 working days.
Storage
Store lyophilized form at 2-8°C for up to 1 month. For longer periods, store lyophilized or liquid at -80°C. Avoid repeated freeze–thaw cycles.
Dry Ice
No
UniProt ID
Q29412
Alias
IFB,IFF,IFNB,IFN-beta,IFN-beta 1,Fibroblast interferon 1,IFNB1
Background
Protein IFNB1
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Reconstitute in ddH2O to a concentration between 0.1-0.5 mg/ml. Do not vortex.
Endotoxin Level: < 1.0 EU per 1 μg (LAL method)
Concentration: Prior to lyophilization: 50 µg/ml

Descripción

Interferon Beta 1 (IFNB1) is a type I interferon with a critical role in antiviral defense and immunoregulation. Produced predominantly by fibroblasts, epithelial cells, and macrophages, IFNB1 is rapidly secreted in response to viral infections and pathogen-associated molecular patterns (PAMPs) recognized by pattern recognition receptors, such as Toll-like receptors (TLRs). Upon secretion, IFNB1 binds to the interferon alpha/beta receptor (IFNAR), triggering the JAK-STAT signaling pathway. This leads to the transcription of interferon-stimulated genes (ISGs), which orchestrate antiviral responses, including the inhibition of viral replication, degradation of viral RNA, and promotion of apoptosis in infected cells. IFNB1 also enhances antigen presentation by upregulating major histocompatibility complex (MHC) class I molecules and bolsters the activation and proliferation of natural killer (NK) cells and cytotoxic T lymphocytes. Clinically, recombinant forms of IFNB1 are widely used in the treatment of multiple sclerosis (MS), where they modulate the inflammatory response and reduce disease progression. Its role in other autoimmune and infectious diseases continues to be an area of active research.

Related Products

ECA0124

Canine IFN-β (Interferon beta) ELISA Kit

Ver Producto
ECH0025

Chicken IFN-β (Interferon Beta) ELISA Kit

Ver Producto
EH0485

Human IFN-β (Interferon beta) ELISA Kit

Ver Producto